SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-13-019920
Filing Date
2013-04-03
Accepted
2013-04-03 15:07:51
Documents
5
Period of Report
2013-04-19
Effectiveness Date
2013-04-03

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A v340300_def14a.htm DEF 14A 495322
2 GRAPHIC image_001.jpg GRAPHIC 1447
3 GRAPHIC image_002.jpg GRAPHIC 3724
4 GRAPHIC image_003.jpg GRAPHIC 4145
5 GRAPHIC image_004.jpg GRAPHIC 3820
  Complete submission text file 0001144204-13-019920.txt   515119
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-54879 | Film No.: 13739210
SIC: 1000 Metal Mining